Literature DB >> 3198893

Prevention of rapidly progressive scoliosis in Duchenne muscular dystrophy by prolongation of walking with orthoses.

E B Rodillo1, E Fernandez-Bermejo, J Z Heckmatt, V Dubowitz.   

Abstract

We reviewed the incidence and severity of scoliosis in 93 boys with Duchenne muscular dystrophy who had been rehabilitated in light-weight knee-ankle-foot orthoses at the point of loss of ambulation, between the ages of 6 and 12 years. There was an inverse relationship between the severity of the scoliosis and the age walking was lost in the orthoses. The scoliosis was less severe in the 20 boys (22%) who walked in their orthoses beyond 13 years of age than in those who stopped walking in their orthoses before 13 years. There was also a rapid deterioration in the scoliosis between the ages of 13 and 15 years in boys who had stopped walking in their orthoses before the age of 13 years, while in comparison, boys of the same age who were ambulant in their orthoses beyond 13 years showed a much slower rate of deterioration. These results strongly suggest that walking in orthoses beyond the age of 13 years prevented rapid progression of scoliosis between 13 and 15 years of age, ie, during the pubertal growth spurt.

Entities:  

Mesh:

Year:  1988        PMID: 3198893     DOI: 10.1177/088307388800300407

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  Lung function in Duchenne muscular dystrophy.

Authors:  C S Galasko; J B Williamson; C M Delaney
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

Review 2.  Assisted standing for Duchenne muscular dystrophy.

Authors:  Katy Pedlow; Suzanne McDonough; Sheila Lennon; Claire Kerr; Ian Bradbury
Journal:  Cochrane Database Syst Rev       Date:  2019-10-13

Review 3.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

4.  A population-based study of scoliosis among males diagnosed with a dystrophinopathy identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Authors:  Kristin M Conway; Amber Gedlinske; Katherine D Mathews; Seth Perlman; Nicholas Johnson; Russell Butterfield; Man Hung; Jerry Bounsanga; Dennis Matthews; Joyce Oleszek; Paul A Romitti
Journal:  Muscle Nerve       Date:  2021-12-01       Impact factor: 3.852

5.  Importance of lower limb surgery in Duchenne muscular dystrophy.

Authors:  R Forst; J Forst
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

Review 6.  Current and Emerging Therapies for Duchenne Muscular Dystrophy.

Authors:  Megan Crone; Jean K Mah
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

7.  A Dutch guideline for the treatment of scoliosis in neuromuscular disorders.

Authors:  Mg Mullender; Na Blom; M De Kleuver; Jm Fock; Wmgc Hitters; Amc Horemans; Cj Kalkman; Jeh Pruijs; Rr Timmer; Pj Titarsolej; Nc Van Haasteren; Mj Van Tol-de Jager; Aj Van Vught; Bj Van Royen
Journal:  Scoliosis       Date:  2008-09-26

Review 8.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

Review 9.  Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy.

Authors:  Ilaria Sanzarello; Luciano Merlini; Francesco Traina; Michele Attilio Rosa; Cesare Faldini
Journal:  Int Sch Res Notices       Date:  2014-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.